Literature DB >> 17392437

Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.

Pholawat Tingpej1, Lucas Smith, Barbara Rose, Hua Zhu, Tim Conibear, Khaled Al Nassafi, Jim Manos, Mark Elkins, Peter Bye, Mark Willcox, Scott Bell, Claire Wainwright, Colin Harbour.   

Abstract

The emergence of virulent Pseudomonas aeruginosa clones is a threat to cystic fibrosis (CF) patients globally. Characterization of clonal P. aeruginosa strains is critical for an understanding of its clinical impact and developing strategies to meet this problem. Two clonal strains (AES-1 and AES-2) are circulating within CF centers in eastern Australia. In this study, phenotypic characteristics of 43 (14 AES-1, 5 AES-2, and 24 nonclonal) P. aeruginosa isolates were compared to gain insight into the properties of clonal strains. All 43 isolates produced bands of the predicted size in PCRs for vfr, rhlI, rhlR, lasA, lasB, aprA, rhlAB, and exoS genes; 42 were positive for lasI and lasR, and none had exoU. Thirty-seven (86%) isolates were positive in total protease assays; on zymography, 24 (56%) produced elastase/staphylolysin and 22 (51%) produced alkaline protease. Clonal isolates were more likely than nonclonal isolates to be positive for total proteases (P = 0.02), to show elastase and alkaline protease activity by zymography (P = 0.04 and P = 0.01, respectively), and to show elastase activity by the elastin-Congo red assay (P = 0.04). There were no other associations with genotype. Overall, increasing patient age was associated with decreasing elastase activity (P = 0.03). Thirty-two (74%) isolates had at least one N-acylhomoserine lactone (AHL) by thin-layer chromatography. rhl-associated AHL detection was associated with the production and level of total protease and elastase activity (all P < 0.01). Thirty-three (77%) isolates were positive for ExoS by Western blot analysis, 35 (81%) produced rhamnolipids, and 34 (79%) showed chitinase activity. Findings suggest that protease activity during chronic infection may contribute to the transmissibility or virulence of these clonal strains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392437      PMCID: PMC1933084          DOI: 10.1128/JCM.02364-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Production of N-acyl homoserine lactones by gram-negative bacteria isolated from contact lens wearers.

Authors:  H Zhu; S J Thuruthyil; M D Willcox
Journal:  Clin Exp Ophthalmol       Date:  2001-06       Impact factor: 4.207

2.  Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases.

Authors:  A R Caballero; J M Moreau; L S Engel; M E Marquart; J M Hill; R J O'Callaghan
Journal:  Anal Biochem       Date:  2001-03       Impact factor: 3.365

3.  Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors.

Authors:  J A Lomholt; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 4.  N-acyl homoserinelactone-mediated gene regulation in gram-negative bacteria.

Authors:  L Eberl
Journal:  Syst Appl Microbiol       Date:  1999-12       Impact factor: 4.022

5.  Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

Authors:  A M Jones; J R Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

6.  Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.

Authors:  Heather Feltman; Grant Schulert; Salman Khan; Manu Jain; Lance Peterson; Alan R Hauser
Journal:  Microbiology       Date:  2001-10       Impact factor: 2.777

7.  The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosa.

Authors:  S L McKnight; B H Iglewski; E C Pesci
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

8.  Identification of a chitin-binding protein secreted by Pseudomonas aeruginosa.

Authors:  J Folders; J Tommassen; L C van Loon; W Bitter
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

9.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.

Authors:  P K Singh; A L Schaefer; M R Parsek; T O Moninger; M J Welsh; E P Greenberg
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

10.  Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis.

Authors:  O Geisenberger; M Givskov; K Riedel; N Høiby; B Tümmler; L Eberl
Journal:  FEMS Microbiol Lett       Date:  2000-03-15       Impact factor: 2.742

View more
  46 in total

1.  Cooperation and cheating in Pseudomonas aeruginosa: the roles of the las, rhl and pqs quorum-sensing systems.

Authors:  Cara N Wilder; Stephen P Diggle; Martin Schuster
Journal:  ISME J       Date:  2011-03-03       Impact factor: 10.302

2.  Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain.

Authors:  Ruth Ann Luna; Laura A Millecker; C Renee Webb; Sally K Mason; Elaine M Whaley; Jeffrey R Starke; Peter W Hiatt; James Versalovic
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

3.  A cell-cell communication signal integrates quorum sensing and stress response.

Authors:  Jasmine Lee; Jien Wu; Yinyue Deng; Jing Wang; Chao Wang; Jianhe Wang; Changqing Chang; Yihu Dong; Paul Williams; Lian-Hui Zhang
Journal:  Nat Chem Biol       Date:  2013-03-31       Impact factor: 15.040

4.  Crystallization and preliminary X-ray crystallographic analysis of a putative nonribosomal peptide synthase AmbB from Pseudomonas aeruginosa.

Authors:  Yiwen Wang; Dewang Li; Xuelu Huan; Lianhui Zhang; Haiwei Song
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-02-19       Impact factor: 1.056

Review 5.  Bacteria-Host Crosstalk: Sensing of the Quorum in the Context of Pseudomonas aeruginosa Infections.

Authors:  Maria V Turkina; Elena Vikström
Journal:  J Innate Immun       Date:  2018-11-14       Impact factor: 7.349

6.  Proteolytic activity of Pseudomonas aeruginosa isolates with TTSS-mediated cytotoxicity and invasiveness to host cells.

Authors:  Małgorzata A Stepińska; Ewa Ołdak; Elzbieta A Trafny
Journal:  Curr Microbiol       Date:  2009-12-03       Impact factor: 2.188

7.  Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Ronald L Gibson; Bonnie W Ramsey; Hemantha D Kulasekara; George Z Retsch-Bogart; Wayne Morgan; Daniel J Wolter; Christopher E Pope; Laura S Houston; Bridget R Kulasekara; Umer Khan; Jane L Burns; Samuel I Miller; Lucas R Hoffman
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

8.  The presence of quorum-sensing genes in Pseudomonas isolates infecting cystic fibrosis and non-cystic fibrosis patients.

Authors:  Leandro Reus Rodrigues Perez; Alice Beatriz Mombach Pinheiro Machado; Afonso Luís Barth
Journal:  Curr Microbiol       Date:  2013-01-03       Impact factor: 2.188

9.  Antibiotic resistance profiles and quorum sensing-dependent virulence factors in clinical isolates of pseudomonas aeruginosa.

Authors:  Huafu Wang; Faping Tu; Zhihong Gui; Xianghong Lu; Weihua Chu
Journal:  Indian J Microbiol       Date:  2013-02-09       Impact factor: 2.461

10.  Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.

Authors:  Lucas R Hoffman; Anthony R Richardson; Laura S Houston; Hemantha D Kulasekara; Willm Martens-Habbena; Mikkel Klausen; Jane L Burns; David A Stahl; Daniel J Hassett; Ferric C Fang; Samuel I Miller
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.